Compassion Meditation for Older Adults
Feasibility Study of Compassion Meditation Intervention for Older Veterans in Primary Care With Anxiety or Mood Disorders
2 other identifiers
interventional
25
1 country
1
Brief Summary
Some older Veterans with psychological distress may under-utilize mental health services due to perceived stigma of symptom-focused interventions. This study was designed to examine the feasibility of a strengths-based compassion training intervention with Veterans ages \> 55 years with anxiety or depressive symptoms. Although this study was focused on feasibility if successful, this line of research could open the door to a novel and effective treatment that widens acceptance by older Veterans with psychological distress.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2019
CompletedFirst Posted
Study publicly available on registry
May 28, 2019
CompletedStudy Start
First participant enrolled
October 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedResults Posted
Study results publicly available
July 5, 2024
CompletedJuly 5, 2024
March 1, 2024
2.6 years
May 23, 2019
September 1, 2023
March 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Enrollment Rate
The proportion of consented subjects among all screened and eligible patients.
36 months
Initiation Rate
The proportion of subjects who initiate the intervention among all consented subjects.
4 months
Completion Rate
The proportion of subjects who complete 6 or more sessions (out of a total of 10 sessions) of intervention among those who start the intervention.
12 weeks
Practice Time at Home
Unanticipated COVID-related restrictions necessitated changing certain outcome measures. Data was not collected for this measure
12 weeks
Secondary Outcomes (5)
Change in Social Connection (SCS-R) From Baseline to Post-intervention
Baseline and 14 weeks
Mean (and SD) Change Scores for Each Inflammatory Biomarker (Hs-CRP, IL-6, and TNF- )
14 weeks
Change in Depression and Anxiety From Baseline to Post-intervention
Baseline and 14 weeks
Satisfaction With Life (SWLS) From Baseline to Post-intervention
Baseline and 14 weeks
Change in Positive Emotions (mDES) From Baseline to Post-intervention
Baseline and 14 weeks
Study Arms (2)
Compassion Meditation (CM) intervention group
EXPERIMENTAL10-week group intervention consisting of compassion meditation training.
Psychoeducational healthy aging group
ACTIVE COMPARATOR10-week group focused on review and discussion of psychoeducational videos related to healthy aging topics
Interventions
10 weekly 90-minute sessions. Sessions 1-3 assist participants in basic mindfulness breathing practices; sessions 4-8 focus on personal analysis of factors underlying difficulties with compassion for self or others; sessions 9 and 10 review content and assist with relapse prevention. \[These were planned as in-person groups but due to the COVID-19 social distancing requirements that started after initiation of cohort 1, the investigators had to retool the intervention for telehealth delivery.\]
The investigators planned to administer a 10-week psychoeducational in-person group focused on topics in healthy aging to examine its feasibility as a control condition for a subsequent randomized controlled trial. This would include use of an existing library of videotaped community-focused talks, such as increasing happiness, mental resilience and health, nutrition, and physical activity. \[Unfortunately, with the switch to telehealth format necessitated by the COVID-19 social distancing requirements, the consensus of the investigators and staff was that these proved too be too dry/"dull/academic" to be a credible attention control in a telehealth format for the target population.\]
Eligibility Criteria
You may qualify if:
- VA San Diego Healthcare System (VASDHS) patient
- current mild-to-moderate anxiety or depressive symptoms as defined by scores between 5 and 14 on the Patient Health Questionnaire (PHQ-9) and or Generalized Anxiety Disorders scale (GAD-7).
- stated intention to attend the 10 group sessions at the scheduled times at the VASDHS in addition to the baseline and follow-up study assessment visits, as well as to complete the outside homework assignments
- provides written informed consent for participation
You may not qualify if:
- no active suicidality/homicidality in the preceding six months
- untreated alcohol or substance use disorders
- changes to psychiatric medications within six months prior to the baseline evaluation
- medical and/or psychiatric instability interfering with current ability to engage in the group sessions and outside homework assignments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA San Diego Healthcare System, San Diego, CA
San Diego, California, 92161, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Unanticipated COVID-related social distancing restrictions necessitated changing to remote assessment and intervention during the first intervention cohort and throughout the remainder of the trial. The lessons learned are valuable in the context of this as a feasibility study, could potentially help future studies of the intervention focused on Veterans with transportation or geographic distance limitations, but hindered our completion of some of the originally planned components of the study.
Results Point of Contact
- Title
- Barton W. Palmer
- Organization
- Veterans Affairs San Diego Healthcare System
Study Officials
- PRINCIPAL INVESTIGATOR
Barton W. Palmer, PhD
VA San Diego Healthcare System, San Diego, CA
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 23, 2019
First Posted
May 28, 2019
Study Start
October 1, 2019
Primary Completion
April 30, 2022
Study Completion
June 30, 2022
Last Updated
July 5, 2024
Results First Posted
July 5, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share